Literature DB >> 27894115

Complement Activation-Related Pseudo-Allergy: A Fresh Look at Hypersensitivity Reactions to Intravenous Iron.

Iain C Macdougall1, Katherine Vernon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27894115     DOI： 10.1159/000451069

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN： 0250-8095            Impact factor:   3.754


× No keyword cloud information.
  12 in total

Review 1.  Prevention and management of acute reactions to intravenous iron in surgical patients.

Authors:  Susana Gómez-Ramírez; Aryeh Shander; Donat R Spahn; Michael Auerbach; Giancarlo M Liumbruno; Stefania Vaglio; Manuel Muñoz
Journal:  Blood Transfus       Date:  2018-10-16       Impact factor: 3.443

2.  The hidden impact of different Blastocystis genotypes on C-3 and IgE serum levels: a matter of debate in asthmatic Egyptian children.

Authors:  Enas A El Saftawy; Noha M Amin; Dina H Hamed; Aly Elkazazz; Sherihan Adel
Journal:  J Parasit Dis       Date:  2019-03-30

3.  Ferumoxytol for the treatment of iron deficiency and iron-deficiency anemia of pregnancy.

Authors:  Jesse Gerb; William Strauss; Richard Derman; Vanessa Short; Ben Mendelson; Huzefa Bahrain; Michael Auerbach
Journal:  Ther Adv Hematol       Date:  2021-05-31

4.  Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind study with a focus on acute hypersensitivity reactions.

Authors:  N Franklin Adkinson; William E Strauss; Kristine Bernard; Robert F Kaper; Iain C Macdougall; Julie S Krop
Journal:  J Blood Med       Date:  2017-09-26

Review 5.  Clinical data for intravenous iron - debunking the hype around hypersensitivity.

Authors:  Maureen Achebe; Thomas G DeLoughery
Journal:  Transfusion       Date:  2020-06-01       Impact factor: 3.157

Review 6.  Intravenous Irons: From Basic Science to Clinical Practice.

Authors:  Sunil Bhandari; Dora I A Pereira; Helen F Chappell; Hal Drakesmith
Journal:  Pharmaceuticals (Basel)       Date:  2018-08-27

7.  A prospective, multi-center, randomized comparison of iron isomaltoside 1000 versus iron sucrose in patients with iron deficiency anemia; the FERWON-IDA trial.

Authors:  Michael Auerbach; David Henry; Richard J Derman; Maureen M Achebe; Lars L Thomsen; John Glaspy
Journal:  Am J Hematol       Date:  2019-07-13       Impact factor: 10.047

8.  Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial.

Authors:  N Franklin Adkinson; William E Strauss; Iain C Macdougall; Kristine E Bernard; Michael Auerbach; Robert F Kaper; Glenn M Chertow; Julie S Krop
Journal:  Am J Hematol       Date:  2018-02-24       Impact factor: 10.047

9.  Involvement of complement activation in the pulmonary vasoactivity of polystyrene nanoparticles in pigs: unique surface properties underlying alternative pathway activation and instant opsonization.

Authors:  Tamás Mészáros; Gergely Tibor Kozma; Taro Shimizu; Koga Miyahara; Keren Turjeman; Tatsuhiro Ishida; Yechezkel Barenholz; Rudolf Urbanics; János Szebeni
Journal:  Int J Nanomedicine       Date:  2018-10-11

Review 10.  Burden of Anemia in Chronic Kidney Disease: Beyond Erythropoietin.

Authors:  Ramy M Hanna; Elani Streja; Kamyar Kalantar-Zadeh
Journal:  Adv Ther       Date:  2020-10-29       Impact factor: 3.845
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.